The Dana-Farber Cancer Institute has reportedly issued retractions for 6 papers, is correcting 31 others, and is evaluating another, according to The Harvard Crimson.
Multiple Myeloma / Plasma Cell Myeloma–Symptoms-Treatment-Prognosis-Support Group medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.
REGN5459, designed to deplete plasma cells while mitigating the cytokine release syndrome, demonstrated deep and durable clinical responses in heavily pretreated relapsed/refractory myeloma.
Toronto, Ontario (Newsfile Corp. - February 22, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is excited to announce the launch of our inaugural multiple myeloma clinical